Study Title
Immuno-PET Imaging of Neuroendocrine Tumors Using 89Zr-DFO-SC16.56, a DLL3-targeting Monoclonal Antibody
Study Details
Description:
The purpose of this study is to look at how safe 89Zr-DFO-SC16.56 is, and how it is processed by the body in people with small cell lung cancer.
Sponsor:
Memorial Sloan Kettering Cancer Center
Government Study Link:
NCT04199741 - Click here to see study onClinicalTrials.gov